Chronic granulomatous disease

From Ganfyd

Jump to: navigation, search

Chronic granulomatous disease (CGD, Bridges–Good syndrome, chronic granulomatous disorder, Quie syndrome) occurs when phagocytes are unable to produce bactericidal superoxide anions (O2-). This genetically mediated problem with multiple genotypes and phenotypes leads to recurrent life-threatening bacterial and fungal infections. The genes associated are:

  • CYBB at Xp21.1 coding for the cytochrome b beta subunit (p91-phox).
  • NCF1 at 7q11.23 coding for neutrophil cytosol factor 1(p47-phox, phagocyte oxidase)
  • NCF2 at 1q25 coding for neutrophil cytosol factor 2 (p67-phox)
  • CYBA at 16q24 coding for the cytochrome b alpha subunit(p22-phox)
  • NOD2 (CARD15) at 16q12 causing Blau syndome (Jab's syndrome)

Variations in some of these genes are associated with other conditions such as sarcoidosis and Crohn's disease.

LogoKeyPointsBox.pngTake care with TNFα blockers as experience with infliximab suggests that TNFα mediated immunity may be critical to prevent serious infections in those with chronic granulomatous disease
Personal tools